RGCC Oncotrail

A Unique Follow-up Test Tailored For Your Specific Type Of Cancer

The complexity of cancer makes personalization vital to cancer treatment. RGCC Oncotrail is a groundbreaking diagnostic tool that is set to revolutionize cancer monitoring and management. The tests are tailored to address specific cancer types, including breast, prostate, colon, melanoma, lung, sarcoma, gastrointestinal, and more.

Sample Type
Whole peripheral blood sample
Sample Size
10-15ml blood
All types
Turnaround Time
21 Days

How it works?

RGCC Oncotrail is a follow-up test that is used to track Circulating Tumor Cells (CTCs). By analyzing CTCs, and the activity of the stemness markers and markers specific to your specific type of cancer, the OncoTrail results add crucial information about your cancer prognosis as it is designed specifically to provide the information specific to your specific type of cancer.

Utilizing cutting-edge technology, this non-invasive approach allows for precise tracking of cancer progression.

How it is done?

The blood sample will be processed at RGCC’s state-of-the-art laboratory in Greece.
Examining circulating tumor cells, which act as prognostic indicators, and analyzing the phenotype and stemness markers they contain can provide essential insights into cancer prognosis and treatment effectiveness.

Why choose RGCC Oncotrail?

CTC Count: Helps to determine the complexity of the disease, studies show a direct correlation between the CTC count and overall tumor burden. The CTC count helps clinicians assess the treatment responses.

Phenotype markers: Phenotype markers serve as important tools for cancer research, facilitating the discovery of new treatment targets and the development of innovative diagnostic and therapeutic approaches. Phenotype markers play a crucial role in guiding treatment decisions.

Stemness markers: Like the Oncotrace test, Oncotrail also provides crucial information on the important cancer stem cells (CSCs) responsible for tumor initiation, progression, metastasis, and treatment resistance.

Which cancers are tested?

Oncotrail test is a comprehensive tool that reveals the presence and concentration of circulating tumor cells (CTCs). The test helps in developing specialized treatment plans for specific forms of cancer, such as Breast cancer, Colon, GI, Melanoma, Lung, Sarcoma, and Prostate.

Breast Cancer
Colon Cancer
Melanoma Cancer
Prostate Cancer
Lung Cancer
Gastrointestinal Cancer
Sarcoma Cancer
Pancreatic Cancer


Book an appointment

The first step towards personalized cancer care is scheduling an appointment with us.


30 minutes value packed consultation

Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.


Finding the right tests

We guide you through the process of selecting the most effective tests for your specific cancer.


Personalized results

We deliver precise results that guide treatment decisions and enhance outcomes.

Why clinicians prefer RGCC Oncotrail than other similar tests?

Dr. Jervin Lim

“RGCC’s Oncotrail test is essential for monitoring cancer progression and treatment response. Its accuracy allows for timely adjustments to therapy, improving patient outcomes and quality of life. A critical tool in personalized cancer care.”

Request a Second Opinion

Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.

Useful Information

OncoTrail test helps in developing an individualized treatment plan tailored for specific types of cancers like Breast cancer, Colon cancer, GI cancer, Melanoma cancer, Lung cancer, Sarcoma cancer, and Prostate cancer.

We suggest undergoing the RGCC ONCOTRAIL test every three months during active cancer treatment to evaluate the efficacy of the ongoing treatment plan.

Every 3 months for 1 year after completing the treatment/surgery to monitor for early relapse/recurrence.

Start your personalized cancer journey with us!

Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.

    Frequently Asked Questions

    • Can tests be conducted during ongoing treatment?

      Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.

    • What happens to my blood sample post-testing?

      Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells.

    • Is a blood sample sufficient?

      Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.

    • Can the origin of a tumor be determined by the tests?

      Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.

    • What tests are effective in identifying the emergence of secondary tumors?

      RGCC Metastat is an effective test for identifying secondary tumors development and its potential location. It helps detect secondary tumors through analyzing Circulating Tumor Cells (CTCs) in the bloodstream. The test provides valuable insights into disease progression and metastasis.

    • How do tests personalize cancer treatment?

      Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.

    • What are CTCs and CSCs?

      Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.

    • Do tests reveal drug response and sensitivity to immunotherapy?

      Tests like ChemoSNiP and CAMBISeq provide information on the body’s response to the drugs and sensitivity to immunotherapy.

    Take the lead in your treatment journey with RGCC OncoTrail

    Looking to stay ahead in your cancer treatment journey? With RGCC Oncotrail, you can gain vital insights into the effectiveness of your ongoing treatments. Choose RGCC Oncotrail and empower yourself with the knowledge to navigate your cancer journey confidently.